dc.contributorUniversidade Estadual Paulista (UNESP)
dc.creatorDe Campos, C. E O P
dc.creatorDe Campos, E. P.
dc.date2014-05-27T11:17:24Z
dc.date2016-10-25T18:12:40Z
dc.date2014-05-27T11:17:24Z
dc.date2016-10-25T18:12:40Z
dc.date1990-12-01
dc.date.accessioned2017-04-06T00:43:03Z
dc.date.available2017-04-06T00:43:03Z
dc.identifierFolha Medica, v. 101, n. 5-6, p. 337-340, 1990.
dc.identifier0015-5454
dc.identifierhttp://hdl.handle.net/11449/64097
dc.identifierhttp://acervodigital.unesp.br/handle/11449/64097
dc.identifier2-s2.0-0025690630
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/886024
dc.languagepor
dc.relationFolha Medica
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectcefamandole
dc.subjectceftriaxone
dc.subjectadolescent
dc.subjectadult
dc.subjectclinical article
dc.subjectdrug efficacy
dc.subjectfemale
dc.subjecthuman
dc.subjectmale
dc.subjectminimum inhibitory concentration
dc.subjectpneumonia
dc.subjectrespiratory tract infection
dc.titleClinical and microbiological comparative study of two cephalosporins (2nd and 3d generations) in acute pulmonary infections
dc.typeOtro


Este ítem pertenece a la siguiente institución